{"id":129212,"date":"2026-06-24T12:00:25","date_gmt":"2026-06-24T06:30:25","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=129212"},"modified":"2026-06-24T12:00:26","modified_gmt":"2026-06-24T06:30:26","slug":"sudeep-pharma-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/","title":{"rendered":"Sudeep Pharma Share Price Target 2026 Analyst Forecast Bull and Bear Case"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>The Sudeep Pharma share price target 2026 is Rs 1,000, implying approximately 20 percent upside from the current market price of Rs 837.8 (NSE: SUDEEPPHRM). With Q4 FY26 results released in 2026 and Pharmaceutical Formulations tailwinds in focus, the Rs 1,000 price objective is supported by the FY27 earnings recovery thesis.<\/em><\/p>\n<p><a href=\"https:\/\/univest.in\/user\/stocks\/sudeepphrm\/sudeep-pharma-ltd-share-price-today\">Sudeep Pharma<\/a> (NSE: SUDEEPPHRM) is a Pharmaceutical Formulations company trading at Rs 837.8 with a market capitalisation of Rs 4,189 crore. Analysts have set the <strong>Sudeep Pharma share price target<\/strong> at Rs 1,000 for 2026, based on FY27 earnings projections and sector re-rating potential. This article covers the complete 2026 price forecast including sector tailwinds, key risks, and bull and bear scenarios.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#Sudeep_Pharma_Share_Price_Target_2026_Key_Takeaways\" title=\"Sudeep Pharma Share Price Target 2026: Key Takeaways\">Sudeep Pharma Share Price Target 2026: Key Takeaways<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#Sudeep_Pharma_Company_Overview\" title=\"Sudeep Pharma Company Overview\">Sudeep Pharma Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#Why_Is_the_Sudeep_Pharma_Share_Price_Target_Set_at_Rs_1000_for_2026\" title=\"Why Is the Sudeep Pharma Share Price Target Set at Rs 1,000 for 2026\">Why Is the Sudeep Pharma Share Price Target Set at Rs 1,000 for 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#FY27_Earnings_Recovery_and_Revenue_Acceleration\" title=\"FY27 Earnings Recovery and Revenue Acceleration\">FY27 Earnings Recovery and Revenue Acceleration<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#Structural_Sector_Tailwinds_in_Pharmaceutical_Formulations\" title=\"Structural Sector Tailwinds in Pharmaceutical Formulations\">Structural Sector Tailwinds in Pharmaceutical Formulations<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\" title=\"RBI Rate Cut Cycle and Lower Cost of Capital\">RBI Rate Cut Cycle and Lower Cost of Capital<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#Union_Budget_2026-27_Capex_Push_and_Policy_Support\" title=\"Union Budget 2026-27 Capex Push and Policy Support\">Union Budget 2026-27 Capex Push and Policy Support<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#FII_Flow_Normalisation_After_the_2026_Tariff_Shock\" title=\"FII Flow Normalisation After the 2026 Tariff Shock\">FII Flow Normalisation After the 2026 Tariff Shock<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#Sudeep_Pharma_Share_Price_Targets_Short_Term_12_Month_and_Long_Term\" title=\"Sudeep Pharma Share Price Targets: Short Term, 12 Month, and Long Term\">Sudeep Pharma Share Price Targets: Short Term, 12 Month, and Long Term<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#Short_Term_Sudeep_Pharma_Share_Price_Target\" title=\"Short Term Sudeep Pharma Share Price Target\">Short Term Sudeep Pharma Share Price Target<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#12-Month_Sudeep_Pharma_Share_Price_Target_2026\" title=\"12-Month Sudeep Pharma Share Price Target 2026\">12-Month Sudeep Pharma Share Price Target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#Long_Term_Sudeep_Pharma_Share_Price_Target_FY27_to_FY28\" title=\"Long Term Sudeep Pharma Share Price Target: FY27 to FY28\">Long Term Sudeep Pharma Share Price Target: FY27 to FY28<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#Bull_Case_and_Bear_Case_Scenarios_for_Sudeep_Pharma_in_2026\" title=\"Bull Case and Bear Case Scenarios for Sudeep Pharma in 2026\">Bull Case and Bear Case Scenarios for Sudeep Pharma in 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#Bull_Case_Sudeep_Pharma_Share_Price_Target_Rs_1200\" title=\"Bull Case Sudeep Pharma Share Price Target: Rs 1,200\">Bull Case Sudeep Pharma Share Price Target: Rs 1,200<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#Bear_Case_Sudeep_Pharma_Share_Price_Target_Rs_670\" title=\"Bear Case Sudeep Pharma Share Price Target: Rs 670\">Bear Case Sudeep Pharma Share Price Target: Rs 670<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#Key_Risks_That_Could_Derail_the_Sudeep_Pharma_2026_Price_Objective\" title=\"Key Risks That Could Derail the Sudeep Pharma 2026 Price Objective\">Key Risks That Could Derail the Sudeep Pharma 2026 Price Objective<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#Global_Macro_and_US_Tariff_Headwinds\" title=\"Global Macro and US Tariff Headwinds\">Global Macro and US Tariff Headwinds<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#FY27_Earnings_Miss_and_Guidance_Risk\" title=\"FY27 Earnings Miss and Guidance Risk\">FY27 Earnings Miss and Guidance Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#Competitive_Intensity_Among_Pharmaceutical_Formulations_Peers\" title=\"Competitive Intensity Among Pharmaceutical Formulations Peers\">Competitive Intensity Among Pharmaceutical Formulations Peers<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#Liquidity_Risk_and_FII_Selling_Pressure\" title=\"Liquidity Risk and FII Selling Pressure\">Liquidity Risk and FII Selling Pressure<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#How_to_Invest_in_Sudeep_Pharma\" title=\"How to Invest in Sudeep Pharma\">How to Invest in Sudeep Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#FAQs_on_Sudeep_Pharma_Share_Price_Target_2026\" title=\"FAQs on Sudeep Pharma Share Price Target 2026\">FAQs on Sudeep Pharma Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#What_is_the_Sudeep_Pharma_share_price_target_for_2026\" title=\"What is the Sudeep Pharma share price target for 2026?\">What is the Sudeep Pharma share price target for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#What_was_the_Sudeep_Pharma_share_price_target_for_2025\" title=\"What was the Sudeep Pharma share price target for 2025?\">What was the Sudeep Pharma share price target for 2025?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#Is_Sudeep_Pharma_a_good_investment_at_Rs_8378\" title=\"Is Sudeep Pharma a good investment at Rs 837.8?\">Is Sudeep Pharma a good investment at Rs 837.8?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#What_are_the_key_risks_to_the_Sudeep_Pharma_share_price_target_2026\" title=\"What are the key risks to the Sudeep Pharma share price target 2026?\">What are the key risks to the Sudeep Pharma share price target 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#What_is_the_52_week_high_and_low_of_Sudeep_Pharma\" title=\"What is the 52 week high and low of Sudeep Pharma?\">What is the 52 week high and low of Sudeep Pharma?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#What_are_the_main_growth_catalysts_for_Sudeep_Pharma_in_2026\" title=\"What are the main growth catalysts for Sudeep Pharma in 2026?\">What are the main growth catalysts for Sudeep Pharma in 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#How_does_Sudeep_Pharma_compare_to_its_peers\" title=\"How does Sudeep Pharma compare to its peers?\">How does Sudeep Pharma compare to its peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-share-price-target-2026\/#What_is_the_Sudeep_Pharma_share_price_target_for_2027\" title=\"What is the Sudeep Pharma share price target for 2027?\">What is the Sudeep Pharma share price target for 2027?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Sudeep_Pharma_Share_Price_Target_2026_Key_Takeaways\"><\/span><strong>Sudeep Pharma Share Price Target 2026: Key Takeaways<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Sudeep Pharma share price target 2026:<\/strong> Rs 1,000 (20% upside from CMP Rs 837.8)<\/li>\n<li><strong>Bull case:<\/strong> Rs 1,200 | <strong>Bear case:<\/strong> Rs 670<\/li>\n<li><strong>Ticker:<\/strong> SUDEEPPHRM | <strong>Sector:<\/strong> Pharmaceutical Formulations | <strong>MCap:<\/strong> Rs 4,189 crore<\/li>\n<li><strong>52W range:<\/strong> Rs 581 to Rs 1,376 | <strong>PE:<\/strong> 25x<\/li>\n<li><strong>Key catalyst:<\/strong> Q4 FY26 results and FY27 earnings confirmation in 2026<\/li>\n<li><strong>Key risk:<\/strong> FY27 earnings miss or FII outflows from Indian equities<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Sudeep_Pharma_Company_Overview\"><\/span><strong>Sudeep Pharma Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Sudeep Pharma (NSE: SUDEEPPHRM) is a pharmaceutical formulations company listed in 2025 manufacturing tablets, capsules, and injectables for domestic and regulated export markets with an integrated facility in Gujarat. At CMP Rs 837.8 against a 52 week range of Rs 581 to Rs 1,376, the stock trades at a meaningful discount to its 52 week high. Market capitalisation is Rs 4,189 crore with trailing PE of 25x. Compared to peers in pharma formulations like Anuh Pharma and Lincoln Pharmaceuticals, Sudeep Pharma is positioned as a potential re-rating candidate toward the Rs 1,000 price objective on FY27 earnings delivery.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Parameter<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>NSE Ticker<\/td>\n<td>SUDEEPPHRM<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Pharmaceutical Formulations<\/td>\n<\/tr>\n<tr>\n<td>CMP (2026)<\/td>\n<td>Rs 837.8<\/td>\n<\/tr>\n<tr>\n<td>52 Week High<\/td>\n<td>Rs 1,376<\/td>\n<\/tr>\n<tr>\n<td>52 Week Low<\/td>\n<td>Rs 581<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 4,189 crore<\/td>\n<\/tr>\n<tr>\n<td>Trailing PE<\/td>\n<td>25x<\/td>\n<\/tr>\n<tr>\n<td>12-Month Analyst Target<\/td>\n<td>Rs 1,000<\/td>\n<\/tr>\n<tr>\n<td>Bull Case Target<\/td>\n<td>Rs 1,200<\/td>\n<\/tr>\n<tr>\n<td>Bear Case Target<\/td>\n<td>Rs 670<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Why_Is_the_Sudeep_Pharma_Share_Price_Target_Set_at_Rs_1000_for_2026\"><\/span><strong>Why Is the Sudeep Pharma Share Price Target Set at Rs 1,000 for 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Earnings_Recovery_and_Revenue_Acceleration\"><\/span><strong>FY27 Earnings Recovery and Revenue Acceleration<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>Sudeep Pharma share price target<\/strong> of Rs 1,000 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results released in 2026 confirming the earnings trajectory are the most direct catalyst for re-rating from CMP Rs 837.8.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Structural_Sector_Tailwinds_in_Pharmaceutical_Formulations\"><\/span><strong>Structural Sector Tailwinds in Pharmaceutical Formulations<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Pharmaceutical Formulations sector is expanding on the back of India&#8217;s domestic demand growth, PLI scheme support, and rising corporate investment. Sudeep Pharma&#8217;s position among peers in pharma formulations like Anuh Pharma and Lincoln Pharmaceuticals creates a structural growth runway. Sustained outperformance is one of the key conditions for the Rs 1,200 bull case to materialise.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\"><\/span><strong>RBI Rate Cut Cycle and Lower Cost of Capital<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s RBI rate cut cycle in 2026 is reducing borrowing costs and stimulating end market demand. Lower interest costs improve Sudeep Pharma&#8217;s EPS trajectory, narrowing the gap between current earnings and the FY27 estimates that underpin the Rs 1,000 analyst consensus.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Union_Budget_2026-27_Capex_Push_and_Policy_Support\"><\/span><strong>Union Budget 2026-27 Capex Push and Policy Support<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Budget 2026-27&#8217;s Rs 11.21 lakh crore infrastructure capex and PLI scheme continuity create a favourable backdrop for Sudeep Pharma&#8217;s Pharmaceutical Formulations operations, improving the probability of achieving the Rs 1,000 price objective through FY27 earnings delivery.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FII_Flow_Normalisation_After_the_2026_Tariff_Shock\"><\/span><strong>FII Flow Normalisation After the 2026 Tariff Shock<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>As global macro conditions normalise through 2026, FII flows into quality Indian equities are gradually recovering. At 25x PE, Sudeep Pharma is positioned as a beneficiary of institutional reallocation toward the Rs 1,200 bull case over the medium term.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sudeep_Pharma_Share_Price_Targets_Short_Term_12_Month_and_Long_Term\"><\/span><strong>Sudeep Pharma Share Price Targets: Short Term, 12 Month, and Long Term<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Short_Term_Sudeep_Pharma_Share_Price_Target\"><\/span><strong>Short Term Sudeep Pharma Share Price Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Near-term support for Sudeep Pharma is anchored close to the 52 week low of Rs 581. A confirmed Q4 FY26 earnings recovery in 2026 is the trigger for an initial 10 to 15 percent re-rating from CMP Rs 837.8.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"12-Month_Sudeep_Pharma_Share_Price_Target_2026\"><\/span><strong>12-Month Sudeep Pharma Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 12-month <strong>Sudeep Pharma share price target 2026<\/strong> is Rs 1,000, implying approximately 20 percent upside from CMP Rs 837.8. This base case assumes in-line FY27 earnings delivery and partial normalisation of FII flows.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Long_Term_Sudeep_Pharma_Share_Price_Target_FY27_to_FY28\"><\/span><strong>Long Term Sudeep Pharma Share Price Target: FY27 to FY28<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>long term Sudeep Pharma share price target<\/strong> for FY27 to FY28 is Rs 1,200 in the bull case, requiring full earnings delivery, re-rating among peers in pharma formulations like Anuh Pharma and Lincoln Pharmaceuticals, and sustained institutional buying over a 2 to 3 year horizon.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bull_Case_and_Bear_Case_Scenarios_for_Sudeep_Pharma_in_2026\"><\/span><strong>Bull Case and Bear Case Scenarios for Sudeep Pharma in 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Bull_Case_Sudeep_Pharma_Share_Price_Target_Rs_1200\"><\/span><strong>Bull Case Sudeep Pharma Share Price Target: Rs 1,200<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>bull case Sudeep Pharma share price target<\/strong> of Rs 1,200 materialises when FY27 earnings beat analyst estimates, Pharmaceutical Formulations tailwinds accelerate, and FII flows return strongly to Indian equities. From CMP Rs 837.8, this represents approximately 45 percent potential upside.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Bear_Case_Sudeep_Pharma_Share_Price_Target_Rs_670\"><\/span><strong>Bear Case Sudeep Pharma Share Price Target: Rs 670<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>bear case Sudeep Pharma share price target<\/strong> of Rs 670 materialises if FY27 earnings disappoint or FII outflows depress the broader market, risking a test of support near the 52 week low of Rs 581.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Scenario<\/th>\n<th>Target<\/th>\n<th>Key Conditions<\/th>\n<\/tr>\n<tr>\n<td>Bull Case<\/td>\n<td>Rs 1,200<\/td>\n<td>FY27 beat, sector re-rating, FII inflows<\/td>\n<\/tr>\n<tr>\n<td>Base Case (Analyst Target)<\/td>\n<td>Rs 1,000<\/td>\n<td>In-line FY27 delivery, partial FII recovery<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 670<\/td>\n<td>FY27 miss, guidance cut, FII outflows persist<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_That_Could_Derail_the_Sudeep_Pharma_2026_Price_Objective\"><\/span><strong>Key Risks That Could Derail the Sudeep Pharma 2026 Price Objective<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Global_Macro_and_US_Tariff_Headwinds\"><\/span><strong>Global Macro and US Tariff Headwinds<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Prolonged tariff tensions and global demand slowdown remain prominent macro risks to the <strong>Sudeep Pharma share price target<\/strong> of Rs 1,000, with FII outflows being the direct transmission mechanism to Indian equity valuations.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Earnings_Miss_and_Guidance_Risk\"><\/span><strong>FY27 Earnings Miss and Guidance Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>An FY27 earnings miss or downward guidance revision would compress valuation multiples and is the most direct company-specific risk to the Rs 1,000 analyst price objective. Investors must monitor quarterly results and management commentary closely.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Competitive_Intensity_Among_Pharmaceutical_Formulations_Peers\"><\/span><strong>Competitive Intensity Among Pharmaceutical Formulations Peers<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Intensifying competition from peers in pharma formulations like Anuh Pharma and Lincoln Pharmaceuticals could compress Sudeep Pharma&#8217;s market share and pricing power, a structural risk that must be weighed when assessing the defensibility of the earnings trajectory underpinning the Rs 1,000 analyst target for 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Liquidity_Risk_and_FII_Selling_Pressure\"><\/span><strong>Liquidity Risk and FII Selling Pressure<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Sustained FII outflows from Indian equities can delay the re-rating process regardless of company-level improvement. Investors should maintain position sizing discipline and stop losses to protect capital.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_Sudeep_Pharma\"><\/span><strong>How to Invest in Sudeep Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data<\/strong><\/a><\/p>\n<p>Before considering any investment based on the <strong>Sudeep Pharma share price target<\/strong> of Rs 1,000, review Q4 FY26 results and FY27 guidance released in 2026. Focus on revenue growth, margin trends, and management commentary on Pharmaceutical Formulations sector demand.<\/p>\n<p>Open a Demat account with a SEBI registered stockbroker to trade Sudeep Pharma (NSE: SUDEEPPHRM) with full regulatory protection. Study the competitive landscape among peers in pharma formulations like Anuh Pharma and Lincoln Pharmaceuticals before executing any position.<\/p>\n<p>Plan your entry using the 52 week low of Rs 581 as a key support reference. A confirmed FY27 earnings uptick validates the entry case for the Rs 1,000 price objective. Always set a stop loss below the 52 week low.<\/p>\n<p>Restrict any single stock to 3 to 5 percent of your total equity portfolio. Always consult a SEBI registered financial advisor before investing. SEBI Registration No. INH000013776.<\/p>\n<p><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or the <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Sudeep Pharma&#8217;s live share price and receive daily stock recommendations.<\/em><\/p>\n<div style=\"background: #C0392B; padding: 20px 24px; border-radius: 4px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 15px; font-weight: bold; margin: 0; line-height: 1.7;\"><strong>Disclaimer Note:<\/strong> The securities quoted, if any, are for illustration only and are not recommendatory. This content is for educational purposes only and does not constitute investment advice. Investments in securities are subject to market risk. Read all related documents carefully before investing. SEBI Registration No. INH000013776.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Sudeep_Pharma_Share_Price_Target_2026\"><\/span><strong>FAQs on Sudeep Pharma Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Sudeep_Pharma_share_price_target_for_2026\"><\/span><strong>What is the Sudeep Pharma share price target for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Sudeep Pharma share price target 2026 is Rs 1,000, implying approximately 20 percent upside from CMP Rs 837.8. Bull case is Rs 1,200, bear case is Rs 670.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_Sudeep_Pharma_share_price_target_for_2025\"><\/span><strong>What was the Sudeep Pharma share price target for 2025?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 2025 price objective for Sudeep Pharma was based on FY26 earnings projections. The current 2026 analyst consensus is Rs 1,000, reflecting FY27 growth potential from CMP Rs 837.8.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Sudeep_Pharma_a_good_investment_at_Rs_8378\"><\/span><strong>Is Sudeep Pharma a good investment at Rs 837.8?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> At Rs 837.8, Sudeep Pharma offers potential upside toward Rs 1,000 if FY27 earnings recover. Whether this represents a good entry depends on individual risk tolerance. Consult a SEBI registered financial advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_to_the_Sudeep_Pharma_share_price_target_2026\"><\/span><strong>What are the key risks to the Sudeep Pharma share price target 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key risks to the Sudeep Pharma share price target of Rs 1,000 include FY27 earnings miss, global tariff headwinds, FII outflows, and competitive pressure in Pharmaceutical Formulations. Monitoring quarterly results is essential.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_52_week_high_and_low_of_Sudeep_Pharma\"><\/span><strong>What is the 52 week high and low of Sudeep Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 52 week high of Sudeep Pharma is Rs 1,376 and the 52 week low is Rs 581. At CMP Rs 837.8, the stock offers potential upside toward the Rs 1,000 price objective.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_main_growth_catalysts_for_Sudeep_Pharma_in_2026\"><\/span><strong>What are the main growth catalysts for Sudeep Pharma in 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key catalysts include FY27 PAT recovery, Pharmaceutical Formulations tailwinds, RBI rate cuts in 2026, Budget 2026-27 policy support, and normalisation of FII flows into Indian equities.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Sudeep_Pharma_compare_to_its_peers\"><\/span><strong>How does Sudeep Pharma compare to its peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sudeep Pharma operates in Pharmaceutical Formulations alongside peers in pharma formulations like Anuh Pharma and Lincoln Pharmaceuticals. At CMP Rs 837.8 with MCap Rs 4,189 crore, it is a potential re-rating candidate toward the Sudeep Pharma share price target of Rs 1,000 on FY27 delivery.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Sudeep_Pharma_share_price_target_for_2027\"><\/span><strong>What is the Sudeep Pharma share price target for 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The long-term Sudeep Pharma share price target for FY27 to FY28 is Rs 1,200 in the bull case, assuming earnings growth, sector re-rating, and FII inflows. Consult a SEBI registered financial advisor for personalised guidance.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the Sudeep Pharma share price target for 2026?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Sudeep Pharma share price target 2026 is Rs 1,000, implying approximately 20 percent upside from CMP Rs 837.8. Bull case is Rs 1,200, bear case is Rs 670.\"}},{\"@type\":\"Question\",\"name\":\"What was the Sudeep Pharma share price target for 2025?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The 2025 price objective for Sudeep Pharma was based on FY26 earnings projections. The current 2026 analyst consensus is Rs 1,000, reflecting FY27 growth potential from CMP Rs 837.8.\"}},{\"@type\":\"Question\",\"name\":\"Is Sudeep Pharma a good investment at Rs 837.8?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"At Rs 837.8, Sudeep Pharma offers potential upside toward Rs 1,000 if FY27 earnings recover. Whether this represents a good entry depends on individual risk tolerance. Consult a SEBI registered financial advisor before investing.\"}},{\"@type\":\"Question\",\"name\":\"What are the key risks to the Sudeep Pharma share price target 2026?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Key risks to the Sudeep Pharma share price target of Rs 1,000 include FY27 earnings miss, global tariff headwinds, FII outflows, and competitive pressure in Pharmaceutical Formulations. Monitoring quarterly results is essential.\"}},{\"@type\":\"Question\",\"name\":\"What is the 52 week high and low of Sudeep Pharma?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The 52 week high of Sudeep Pharma is Rs 1,376 and the 52 week low is Rs 581. At CMP Rs 837.8, the stock offers potential upside toward the Rs 1,000 price objective.\"}},{\"@type\":\"Question\",\"name\":\"What are the main growth catalysts for Sudeep Pharma in 2026?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Key catalysts include FY27 PAT recovery, Pharmaceutical Formulations tailwinds, RBI rate cuts in 2026, Budget 2026-27 policy support, and normalisation of FII flows into Indian equities.\"}},{\"@type\":\"Question\",\"name\":\"How does Sudeep Pharma compare to its peers?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Sudeep Pharma operates in Pharmaceutical Formulations alongside peers in pharma formulations like Anuh Pharma and Lincoln Pharmaceuticals. At CMP Rs 837.8 with MCap Rs 4,189 crore, it is a potential re-rating candidate toward the Sudeep Pharma share price target of Rs 1,000 on FY27 delivery.\"}},{\"@type\":\"Question\",\"name\":\"What is the Sudeep Pharma share price target for 2027?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The long-term Sudeep Pharma share price target for FY27 to FY28 is Rs 1,200 in the bull case, assuming earnings growth, sector re-rating, and FII inflows. Consult a SEBI registered financial advisor for personalised guidance.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>The Sudeep Pharma share price target 2026 is Rs 1,000, ~20% upside from CMP Rs 837.8. Bull Rs 1,200, bear Rs 670. 2026.<\/p>\n","protected":false},"author":35,"featured_media":129371,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-129212","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1782282639:26"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["76"],"rank_math_focus_keyword":["Sudeep Pharma Share Price Target 2026"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Sudeep Pharma Share Price Target 2026: Rs 1,000 Analyst Forecast"],"rank_math_description":["The Sudeep Pharma share price target 2026 is Rs 1,000, ~20% upside from CMP Rs 837.8. Bull Rs 1,200, bear Rs 670. 2026."],"_thumbnail_id":["129371"],"_edit_last":["26"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["20737"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/06\/Sudeep-Pharma-Share-Price-Target-2026.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/129212","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=129212"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/129212\/revisions"}],"predecessor-version":[{"id":129374,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/129212\/revisions\/129374"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/129371"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=129212"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=129212"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=129212"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}